EU Safety Gate (RAPEX) · France · 2024-09-06 · Serious risk
🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: Le produit contient du 2-(4-tert-butylbenzyl) propionaldéhyde (BMHCA), qui est interdit dans les produits cosmétiques. Le BMHCA peut nuire au système reproducteur, peut nuire à la santé de l'enfant à naître et peut provoquer une sensibilisation cutanée. Le produit ne respecte pas le règlement sur les produits cosmétiques.
Action taken by the authority
Type of economic operator taking notified measure
Other
Category of measure
Removal of this product listing by the online marketplace
Date of entry into force
03/07/2024
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): HYALURONIC ACID – FACIAL SERUM
Risk Description (original English): The product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the unborn child and may cause skin sensitisation.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.